Terrance Johns

Search results

• 2022

  ENHANCING ANTI-CD47 MAB EFFICACY WITH RADIOTHERAPY FOR GROUP 3 PAEDIATRIC MEDULLOBLASTOMA IN PRECLINICAL MODELS

  Abbas, Z., Buck, J., Ancliffe, M., Arias, C. A., Howlett, M., Hii, H., Johns, T., Mitra, S., Gottardo, N. & Endersby, R., Jun 2022, In: Neuro-Oncology. 24, p. 172-172 1 p.

  Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

• ENHANCING THE ACTIVITY OF ANTI-CD47 ANTIBODY THERAPY WITH RADIOTHERAPY IN PRECLINICAL MODELS OF MEDULLOBLASTOMA

  Abbas, Z., Howlett, M., Buck, J., Hii, H., Kuchibhotla, M., Ancliffe, M., Whitehouse, J., Johns, T., Ebert, M., Gottardo, N. & Endersby, R., 5 Sept 2022, In: Neuro-Oncology. 24, 1 p.

  Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
  1 Citation (Web of Science)

• How do potassium channels contribute to the growth and invasion of highly-aggressive brain cancers?

  Boyle, Y., Fletcher, E. & Johns, T., Jun 2022, In: Neuro-Oncology. 24, p. 18-18 1 p.

  Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
• 2021

  Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided Therapies (LUMOS) Study

  Kong, B., Sim, H-W., Amanuel, B., Day, B., Buckland, M., Verhaak, R., Yip, S., Johns, T., Lwin, Z., Rosenthal, M., Nowak, A. K., Barnes, E. H., Scott, A. M., Parkinson, J., Jeffree, R., Lourenco, R. D. A., Lau, P., Whittle, J., Hovey, E., Cher, L., & 9 othersKichendasse, G., Hall, M., Robinson, C., Thomas, M., Giardina, T., Tu, E., Khasraw, M., Koh, E-S. & Gan, H., Nov 2021, In: Neuro-Oncology. 23, p. 106-106 1 p.

  Research output: Contribution to journal › Abstract/Meeting Abstract